Indirect Comparison of the Efficacy of Melphalan-Prednisone-Bortezomib Relative to Melphalan-Prednisone-Thalidomide and Melphalan-Prednisone for the First Line Treatment of Multiple Myeloma

被引:0
|
作者
Yeh, Yating [1 ]
Chambers, James [1 ]
Gaugris, Sabine [2 ]
Jansen, Jeroen [1 ]
机构
[1] Mapi Values, Boston, MA USA
[2] Janssen Cilag Ltd, Market Access, High Wycombe, Bucks, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:825 / 825
页数:1
相关论文
共 50 条
  • [1] Modified dose of melphalan-prednisone in multiple myeloma patients receiving bortezomib plus melphalan-prednisone treatment
    Lee, Se Ryeon
    Choi, Hojoon
    Lee, Byung Hyun
    Kang, Ka-Won
    Yu, Eun Sang
    Kim, Dae Sik
    Park, Yong
    Choi, Chul Won
    Kim, Byung Soo
    Sung, Hwa Jung
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (06): : 1333 - 1346
  • [2] Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma
    Palumbo, Antonio
    Ambrosini, Maria Teresa
    Benevolo, Giulia
    Pregno, Patrizia
    Pescosta, Norbert
    Callea, Vincenzo
    Cangialosi, Clotilde
    Caravita, Tommaso
    Morabito, Fortunato
    Musto, Pellegrino
    Bringhen, Sara
    Falco, Patrizia
    Avonto, Ilaria
    Cavallo, Federica
    Boccadoro, Mario
    BLOOD, 2007, 109 (07) : 2767 - 2772
  • [3] Melphalan, prednisone, and lenalidomide versus melphalan, prednisone, and thalidomide in untreated multiple myeloma
    Zweegman, Sonja
    van der Holt, Bronno
    Mellqvist, Ulf-Henrik
    Salomo, Morten
    Bos, Gerard M. J.
    Levin, Mark-David
    Visser-Wisselaar, Heleen
    Hansson, Markus
    van der Velden, Annette W. G.
    Deenik, Wendy
    Gruber, Astrid
    Coenen, Juleon L. L. M.
    Plesner, Torben
    Klein, Saskia K.
    Tanis, Bea C.
    Szatkowski, Damian L.
    Brouwer, Rolf E.
    Westerman, Matthijs
    Leys, M. B. L.
    Sinnige, Harm A. M.
    Haukas, Einar
    van der Hem, Klaas G.
    Durian, Marc F.
    Mattijssen, E. J. M.
    van de Donk, Niels W. C. J.
    Stevens-Kroef, Marian J. P. L.
    Sonneveld, Pieter
    Waage, Anders
    BLOOD, 2016, 127 (09) : 1109 - 1116
  • [4] Bortezomib- melphalan-prednisone: what pattern for bortezomib in multiple myeloma?
    Fouquet, Guillemette
    Leleu, Xavier
    HEMATOLOGIE, 2015, 21 (03): : 157 - 159
  • [5] Efficacy of Lenalidomide in Patients with Multiple Myeloma Previously Treated by Melphalan-Prednisone and Thalidomide
    Michel, Jessica
    Revuz, Sabine
    Tardy, Stephanie
    Fouquet, Guillemette
    Roussel, Murielle
    Balasanu, Oana
    Bologna, Serge
    Bonmati, Caroline
    Perrot, Aurore
    Ranta, Dana
    Feugier, Pierre
    Attal, Michel
    Leleu, Xavier
    Facon, Thierry
    Hulin, Cyrille
    BLOOD, 2012, 120 (21)
  • [6] Bortezomib plus Melphalan and Prednisone for Multiple Myeloma
    Avvisati, Giuseppe
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (24): : 2613 - 2613
  • [7] Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: A Randomized Controlled Trial
    Palumbo, Antonio
    Bringhen, Sara
    Rossi, Davide
    Cavalli, Maide
    Larocca, Alessandra
    Ria, Roberto
    Offidani, Massimo
    Patriarca, Francesca
    Nozzoli, Chiara
    Guglielmelli, Tommasina
    Benevolo, Giulia
    Callea, Vincenzo
    Baldini, Luca
    Morabito, Fortunato
    Grasso, Mariella
    Leonardi, Giovanna
    Rizzo, Manuela
    Falcone, Antonietta Pia
    Gottardi, Daniela
    Montefusco, Vittorio
    Musto, Pellegrino
    Petrucci, Maria Teresa
    Ciccone, Giovannino
    Boccadoro, Mario
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (34) : 5101 - 5109
  • [8] Pharmacogenomic (PGx) Analysis of Bortezomib-Associated Peripheral Neuropathy in the Phase 3 VISTA Trial of Bortezomib Plus Melphalan-Prednisone Versus Melphalan-Prednisone in Multiple Myeloma
    Ricci, Deborah S.
    Favis, Reyna
    Sun, Yu
    van de Velde, Helgi
    Broderick, Erin
    Meyers, Michael
    Harousseau, Jean-Luc
    Avet-Loiseau, Herve
    Richardson, Paul G.
    San Miguel, Jesus F.
    BLOOD, 2009, 114 (22) : 1491 - 1491
  • [9] Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma
    San Miguel, Jesus F.
    Schlag, Rudolf
    Khuageva, Nuriet K.
    Dimopoulos, Meletios A.
    Shpilberg, Ofer
    Kropff, Martin
    Spicka, Ivan
    Petrucci, Maria T.
    Palumbo, Antonio
    Samoilova, Olga S.
    Dmoszynska, Anna
    Abdulkadyrov, Kudrat M.
    Schots, Rik
    Jiang, Bin
    Mateos, Maria-Victoria
    Anderson, Kenneth C.
    Esseltine, Dixie L.
    Liu, Kevin
    Cakana, Andrew
    van de Velde, Helgi
    Richardson, Paul G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (09): : 906 - 917
  • [10] Oral melphalan, prednisone and thalidomide for multiple myeloma.
    Palumbo, A
    Bringhen, S
    Musto, P
    Caravita, T
    Capozzi, R
    Callea, V
    Cangialosi, C
    Montanaro, M
    Catalano, L
    Grasso, M
    Petti, MC
    Merla, M
    Falchi, L
    Omedè, P
    Ceccarelli, M
    Ambrosini, MT
    Avonto, I
    Gay, F
    Falco, P
    Boccadoro, M
    BLOOD, 2005, 106 (11) : 230A - 230A